In: Stocks and Security Research

Sientra Inc. Update
Sientra Inc. (SIEN): Bound for a Significant Move. Our Price Target Increased.
July 3, 2018

Sientra Inc. (SIEN) 12 – 18m Price Target: $38.00 Price: $19.90 Upside: 90% We first wrote about Sientra Inc. on August…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More
Teva Pharmaceuticals (TEVA): Bullish Narrative Continues, Our PT Stands
June 28, 2018

Teva Pharmaceutical Inc. (TEVA) 12 – 18m Price Target: $40.00 Price: $23.75 Upside: 68% On March 11, 2018, we published a…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More
Sientra Inc. (SIEN): Acquisition around the corner?
June 6, 2018

Since its inception, Sientra was quickly able to establish itself as one of the best providers of breast implants and tissue…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More
TEVA PHARMACEUTICAL INC. (TEVA): Possibly the most undervalued global pharmaceutical company?
March 11, 2018

BUSINESS OVERVIEW Teva pharmaceuticals (TEVA) is a pharmaceutical company that operates globally, with significant foothold in United States, Europe, and various…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More
CohBar Inc. (CWBR): Battle with Time and Aging
October 9, 2017

CohBar inc. (CWBR) is known as the leader in the emerging field of mitochondria-based therapeutics for treatment of age-related diseases. Their main focus…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More
Sientra, Inc. (SIEN): Turn around story near completion
August 18, 2017

Sientra, Inc. is a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. Its products include breast…

To access this post, you must purchase Bronze Plan, Gold Plan or Silver Plan.
Read More